| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 111.08▲ | 110.86▲ | 110.53▲ | 100.42▲ | 95.31▲ |
| MA10 | 110.96▲ | 110.35▲ | 108.84▲ | 95.95▲ | 88.49▲ |
| MA20 | 110.84▲ | 107.50▲ | 102.81▲ | 92.90▲ | 83.49▲ |
| MA50 | 110.20▲ | 99.36▲ | 95.77▲ | 86.35▲ | 80.74▲ |
| MA100 | 108.51▲ | 95.21▲ | 93.78▲ | 82.28▲ | 92.14▲ |
| MA200 | 102.73▲ | 93.12▲ | 89.83▲ | 80.94▲ | 80.91▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.016▼ | -0.123▼ | 0.704▲ | 1.677▲ | 2.731▲ |
| RSI | 62.798▲ | 81.672▲ | 87.366▲ | 84.478▲ | 73.925▲ |
| STOCH | 60.008 | 94.700▲ | 96.948▲ | 73.577 | 90.660▲ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -0.536▲ | -0.316▲ |
| CCI | 120.969▲ | 98.999 | 83.251 | 238.560▲ | 233.867▲ |
|
Thursday, November 21, 2019 01:04 AM
Research analysts at Oppenheimer started coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) in a note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage set an ...
|
|
Wednesday, November 20, 2019 08:16 PM
The FDA’s approval of Alnylam’s Gilvaari treatment is the first approval of its kind for acute hepatic porphyria. Alnylam Pharmaceuticals (NASDAQ:ALNY) has officially received the nod from the US Food ...
|
|
Wednesday, November 20, 2019 05:46 PM
The FDA approved the Alynlam (NASDAQ: ALNY) drug givosiran (Givlaari) for acute hepatic porphyria (AHP), a disease caused by a genetic defect that leads to an abnormal accumulation of toxic enzymes ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/11/19 | 107.00 | 111.32 | 104.54 | 111.20 | 1,728,700 |
| 20/11/19 | 97.98 | 109.71 | 97.98 | 108.21 | 2,249,800 |
| 19/11/19 | 93.92 | 99.92 | 93.89 | 97.93 | 1,244,900 |
| 18/11/19 | 92.00 | 93.02 | 90.47 | 92.73 | 729,200 |
| 15/11/19 | 90.57 | 92.39 | 90.27 | 92.05 | 358,400 |
| 14/11/19 | 90.73 | 90.83 | 88.93 | 90.46 | 646,500 |
| 13/11/19 | 90.55 | 91.95 | 89.75 | 90.58 | 640,700 |
| 12/11/19 | 92.20 | 93.09 | 90.55 | 90.85 | 426,500 |
| 11/11/19 | 93.10 | 93.53 | 91.57 | 92.45 | 278,000 |
| 08/11/19 | 91.50 | 93.98 | 90.85 | 93.03 | 536,600 |
|
|
||||
|
|
||||
|
|